Androgen receptor outwits prostate cancer drugs. (Q53907010)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Androgen receptor outwits prostate cancer drugs.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

Androgen receptor outwits prostate cancer drugs. (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

prostate cancer

1 reference

based on heuristic

inferred from title

William B Isaacs

2

object named as

William B Isaacs

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

author name string

John T Isaacs

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

language of work or name

0 references

publication date

1 January 2004

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

Nature Medicine

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

10

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

1

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

26-27

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

Molecular determinants of resistance to antiandrogen therapy

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

Is the Achilles' heel for prostate cancer therapy a gain of function in androgen receptor signaling?

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

Antagonist/agonist balance of the nonsteroidal antiandrogen bicalutamide (Casodex) in a new prostate cancer model

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

Androgen receptor gene amplification and protein expression in hormone refractory prostate cancer.

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

Flutamide withdrawal syndrome: its impact on clinical trials in hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

The transcriptional co-activator cAMP response element-binding protein-binding protein is expressed in prostate cancer and enhances androgen- and anti-androgen-induced androgen receptor function

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

Reducing the agonist activity of antiandrogens by a dominant-negative androgen receptor coregulator ARA70 in prostate cancer cells

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

Heparin-binding epidermal growth factor-like growth factor stimulates androgen-independent prostate tumor growth and antagonizes androgen receptor function

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of LNCaP prostate tumor growth in vivo by an antisense oligonucleotide directed against the human androgen receptor

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

Melatonin elicits nuclear exclusion of the human androgen receptor and attenuates its activity

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

Silymarin inhibits function of the androgen receptor by reducing nuclear localization of the receptor in the human prostate cancer cell line LNCaP.

1 reference

https://api.crossref.org/works/10.1038%2FNM0104-26

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/NM0104-26

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 May 2018

http://europepmc.org/abstract/MED/14702629

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53907010&oldid=2212320990"